The exact role of GLUT5 in colon cancer is not yet fully elucidated, but other studies have shown that the inhibition of GLUT5 in CRC patients is linked to a decrease in the viability of the cancer cells. Here, SLC2A5 is linked to malignant colon neoplasm.